These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17063263)

  • 21. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
    Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF1 and risk of additional breast cancer in the WHEL study.
    Al-Delaimy WK; Flatt SW; Natarajan L; Laughlin GA; Rock CL; Gold EB; Caan BJ; Parker BA; Pierce JP
    Endocr Relat Cancer; 2011 Apr; 18(2):235-44. PubMed ID: 21263044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
    Voskuil DW; Bosma A; Vrieling A; Rookus MA; van 't Veer LJ
    Breast Cancer Res Treat; 2004 Apr; 84(3):225-33. PubMed ID: 15026620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
    Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
    Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
    Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
    Wagner K; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY; Subramanian A; Mokbel K; Sharma AK
    J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
    Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
    Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
    Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
    Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer.
    Choi JY; Lee KM; Noh DY; Ahn SH; Lee JE; Han W; Jang IJ; Shin SG; Yoo KY; Hayes RB; Kang D
    Breast Cancer Res Treat; 2006 Nov; 100(2):213-8. PubMed ID: 16821086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
    González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.